Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicenter DPV study on 24 011 patients from Germany, Austria or Luxembourg.

MLA

Bohn, Barbara, et al. “Oral Contraception in Adolescents with Type 1 Diabetes and Its Association with Cardiovascular Risk Factors. A Multicenter DPV Study on 24 011 Patients from Germany, Austria or Luxembourg.” Pediatric Diabetes, vol. 19, no. 5, Aug. 2018, pp. 937–44. EBSCOhost, https://doi.org/10.1111/pedi.12656.

APA

Bohn, B., Mönkemöller, K., Hilgard, D., Dost, A., Schwab, K. O., Lilienthal, E., Hammer, E., Hake, K., Fritsch, M., Gohlke, B., de Beaufort, C., Holl, R. W., & on behalf of the DPV‐initiative. (2018). Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicenter DPV study on 24 011 patients from Germany, Austria or Luxembourg. Pediatric Diabetes, 19(5), 937–944. https://doi.org/10.1111/pedi.12656

Chicago

Bohn, Barbara, Kirsten Mönkemöller, Dörte Hilgard, Axel Dost, Karl Otfried Schwab, Eggert Lilienthal, Elke Hammer, et al. 2018. “Oral Contraception in Adolescents with Type 1 Diabetes and Its Association with Cardiovascular Risk Factors. A Multicenter DPV Study on 24 011 Patients from Germany, Austria or Luxembourg.” Pediatric Diabetes 19 (5): 937–44. doi:10.1111/pedi.12656.